A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/2074444

Download in:

View as

Triples

General Info

PMID
2074444